DxNow
Portable Bio-imaging Systems & Microfluidic-Based Consumables
Industry
Digital Health
Founded
2013
Size
12 employees
Funding
$172,000
About
DxNow develops portable bio-imaging systems based on microfluidic technology based consumables for application in life science industry. The technology is based on the proprietary technology developed in Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM Labs) at Harvard Medical School/Brigham & Women’s Hospital and Stanford Medicine. The company's product line includes CE marked FERTILE (Microfluidic sperm sorting chips) for ICSI and FERTILE PLUS for ICSI, IUI and IVF, CSI-Q, a Chip-based sperm identification and quantitation cartridges, and NGDE (Next-Generation Differential Extraction) system.